Showing results (201-210 of 397) with videos related to
Sort By:
Pageof 40
European Journal of Heart Failure|January 6, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failureDaan Ceelen, Adriaan A Voors, Jasper Tromp, et al.The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.European Journal of Heart Failure|May 8, 2007
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of CardiologyMarco Metra, Piotr Ponikowski, Kenneth Dickstein, et al.Clinical Cardiology|May 7, 2021
Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failureMasatake Kobayashi, Adriaan A Voors, Wouter Ouwerkerk, et al.European Heart Journal|May 27, 2015
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trialJan Steffel, Michele Robertson, Jagmeet P Singh, et al.European Heart Journal|March 31, 2009
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failureArne Yndestad, Linn Landrø, Thor Ueland, et al.European Heart Journal|April 21, 2017
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trialJeroen J Bax, Victoria Delgado, Peter Sogaard, et al.International Journal of Cardiology|May 4, 2016
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approvalFaiez Zannad, Patrick Rossignol, Wendy Gattis Stough, et al.JAMA|April 24, 2003
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialHenry R Black, William J Elliott, Gregory Grandits, et al.Pageof 40